Theravance Biopharma TBPH Business Segments — Other General And Administrative Expense

Similar metrics at other companies

XOMASingle Reportable — Other General And Administrative Expense

$11.04M+55.7%

SRRKSingle Reportable — Other General And Administrative Expense

$16.13M+80.4%

CAPRSingle Reportable — Other General And Administrative Expense

$4.12M+199%

AVBPSingle Reportable — Other General And Administrative Expense

$2.31M+7.4%

EWTXSingle Reportable — Other General Expense

$6.2M+38.8%

ACLSSingle Reportable — General And Administrative Expense

$26.76M+54.2%

Questions, answered.

What is Theravance Biopharma's business segments — other general and administrative expense?

Theravance Biopharma (TBPH) reported business segments — other general and administrative expense of $7.96M in Q1 2026.

How has Theravance Biopharma's business segments — other general and administrative expense changed year-over-year?

Theravance Biopharma's business segments — other general and administrative expense increased by 9.7% year-over-year, from $7.26M to $7.96M.

What is the long-term trend for Theravance Biopharma's business segments — other general and administrative expense?

Over 2 years (2023 to 2025), Theravance Biopharma's business segments — other general and administrative expense has grown at a -4.0% compound annual growth rate (CAGR), from $31.93M to $29.44M.

What does business segments — other general and administrative expense mean?

This encompasses the broad corporate overhead costs not directly tied to research or marketing, such as legal, finance, and executive management expenses. It is a key metric for evaluating the company's operational discipline and administrative cost control.